ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 33 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $469 | -90.2% | 474 | -86.7% | 0.00% | – |
Q4 2023 | $4,798 | – | 3,554 | +1694.9% | 0.00% | – |
Q2 2023 | $0 | – | 198 | +266.7% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 54 | -99.8% | 0.00% | – |
Q2 2022 | $34,000 | +385.7% | 35,362 | +586.1% | 0.00% | – |
Q4 2021 | $7,000 | +133.3% | 5,154 | +294.6% | 0.00% | – |
Q3 2021 | $3,000 | -57.1% | 1,306 | -49.8% | 0.00% | – |
Q2 2021 | $7,000 | -91.8% | 2,600 | -88.4% | 0.00% | – |
Q1 2021 | $85,000 | +372.2% | 22,465 | +190.5% | 0.00% | – |
Q4 2020 | $18,000 | +1700.0% | 7,734 | +2309.3% | 0.00% | – |
Q3 2020 | $1,000 | -95.0% | 321 | -96.9% | 0.00% | – |
Q2 2020 | $20,000 | +122.2% | 10,459 | +443.6% | 0.00% | – |
Q4 2019 | $9,000 | +200.0% | 1,924 | -57.2% | 0.00% | – |
Q3 2019 | $3,000 | +50.0% | 4,500 | +336.0% | 0.00% | – |
Q1 2019 | $2,000 | – | 1,032 | +391.4% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 210 | -18.9% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 259 | +23.3% | 0.00% | – |
Q2 2018 | $1,000 | – | 210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SEEDS INVESTOR LLC | 189,941 | $188,042 | 0.10% |
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 198,400 | $196,416 | 0.02% |
BRAVE ASSET MANAGEMENT INC | 25,000 | $24,667 | 0.01% |
HEADINVEST, LLC | 17,434 | $17,260 | 0.00% |
Ausdal Financial Partners, Inc. | 21,000 | $20,790 | 0.00% |
Long Focus Capital Management, LLC | 40,000 | $39,600 | 0.00% |
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 15,000 | $14,850 | 0.00% |
Virtu Financial LLC | 27,442 | $27 | 0.00% |
Activest Wealth Management | 5,000 | $4,950 | 0.00% |
PROFESSIONAL ADVISORY SERVICES INC | 10,000 | $10 | 0.00% |